{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiegyfinatddx723lq3mdsmtt5uhqc5tejcuwhdxglt6crzfkwsegm",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mjl3szo7uzj2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreichgmt4v635fzuva57iqo6xpuzyepskhjwcwfixypet3f7qjwnhbi"
    },
    "mimeType": "image/jpeg",
    "size": 777256
  },
  "path": "/news/2026-04-buprenorphine-safe-treatment-opioid-addiction.html",
  "publishedAt": "2026-04-15T18:30:07.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Children born to mothers who used buprenorphine for opioid addiction during pregnancy do not have a greater risk of neurodevelopmental disorders, such as ADHD and autism, compared with children whose mothers took methadone, finds a large US study published by The BMJ.",
  "title": "Buprenorphine found to be a safe treatment for opioid addiction in pregnancy"
}